Middle East & Africa Antifungal Drugs Market Size & Outlook
The antifungal drugs market in Middle East & Africa is expected to reach a projected revenue of US$ 1,509.6 million by 2033. A compound annual growth rate of 5% is expected of Middle East & Africa antifungal drugs market from 2026 to 2033.
- Pharmaceuticals
- Infectious Disease Treatment
- Antifungal Drugs Market Outlook
- Infectious Disease Treatment
Revenue, 2025 (US$M)
$1,023.6
Estimate, 2026 (US$M)
$1,069.9
Forecast, 2033 (US$M)
$1,509.6
CAGR, 2026 - 2033
5.0%
Global Market
Related Markets
Prism AI by Grand View ResearchFree to try
Ask a question about the antifungal drugs market
Every figure cited from GVR research
MEA antifungal drugs market highlights
- The MEA antifungal drugs market generated a revenue of USD 1,023.6 million in 2025.
- The market is expected to grow at a CAGR of 5% from 2026 to 2033.
- In terms of segment, azoles was the largest revenue generating drug class in 2025.
- Echinocandins is the most lucrative drug class segment registering the fastest growth during the forecast period.
- Country-wise, Saudi Arabia is expected to register the highest CAGR from 2026 to 2033.
MEA data book summary
| Market revenue in 2025 | USD 1,023.6 million |
| Market revenue in 2033 | USD 1,509.6 million |
| Growth rate | 5% (CAGR from 2026 to 2033) |
| Largest segment | Azoles |
| Fastest growing segment | Echinocandins |
| Historical data covered | 2021 - 2024 |
| Base year for estimation | 2025 |
| Forecast period covered | 2026 - 2033 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Azoles, Echinocandins, Polyenes, Allylamines |
| Key market players worldwide | Novartis AG ADR, Pfizer Inc, Bayer AG, Sanofi SA, Merck KGaA, Merck & Co Inc, GlaxoSmithKline, Abbott Laboratories, Enzon Pharmaceuticals Inc, Astellas Pharma Inc, Glenmark Pharmaceuticals |
Other key industry trends
- In terms of revenue, MEA region accounted for 6.0% of the global antifungal drugs market in 2025.
- Globally, North America is projected to lead the regional market in terms of revenue in 2033.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 5,922.9 million by 2033.
No credit card required*
Publish Date: Jan 13, 2026
Customize the Report
20% free customization
- Include
- Countries, segments, points
- Tailor
- To your product definition
- Extend
- Deeper competitor detail
- Or
- A fully bespoke study
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Antifungal Drugs Market Scope
Antifungal Drugs Market segmentation & scope
Antifungal Drugs Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Novartis AG ADR | View profile | 76,057 | Lichtstrasse 35, Basel, Switzerland, 4056 | www.novartis.com |
| Merck KGaA | View profile | 62,345 | Frankfurter Strasse 250, Darmstadt, HE, Germany, 64293 | www.emdgroup.com |
| Abbott Laboratories | View profile | 114,000 | 100 Abbott Park Road, Abbott Park, IL, United States, 60064-6400 | www.abbottinvestor.com |
| Pfizer Inc | View profile | 88,000 | 66 Hudson Boulevard East, New York, NY, United States, 10001-2192 | www.pfizer.com |
| Sanofi SA | View profile | 87,994 | 46, avenue de la Grande Armée, Paris, France, 75017 | www.sanofi.com |
| Merck & Co Inc | View profile | 72,000 | 126 East Lincoln Avenue, Rahway, NJ, United States, 07065 | www.merck.com |
| Bayer AG | View profile | 99,723 | Kaiser-Wilhelm-Allee 1, Leverkusen, NW, Germany, 51368 | www.bayer.com |
| Enzon Pharmaceuticals Inc | View profile | 1 | 20 Commerce Drive, Suite 135, Cranford, NJ, United States, 07016 | www.enzon.com |
| Astellas Pharma Inc | View profile | 14,484 | 2-5-1, Nihonbashi-Honcho, Chuo-ku, Tokyo, Japan, 103-8411 | www.astellas.com |
| GlaxoSmithKline | View profile | 10001+ | London, England, United Kingdom, Europe | www.gsk.com |
Middle East & Africa Antifungal Drugs Market Outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to Antifungal Drugs Market Outlook will help companies and investors design strategic landscapes.
Azoles was the largest segment with a revenue share of 50.24% in 2025.
Horizon Databook has segmented the Middle East & Africa antifungal drugs market based on azoles, echinocandins, polyenes, allylamines covering the revenue growth of each sub-segment from 2021 to 2033.
- Middle East & Africa Antifungal Drugs Market Drug Class Outlook (Revenue, USD Million , 2021-2033)
- Azoles
- Echinocandins
- Polyenes
- Allylamines
- Others
- Middle East & Africa Antifungal Drugs Market Indication Outlook (Revenue, USD Million , 2021-2033)
- Dermatophytosis
- Aspergillosis
- Candidiasis
- Others
- Middle East & Africa Antifungal Drugs Market Dosage Form Outlook (Revenue, USD Million , 2021-2033)
- Oral Drugs
- Ointments
- Powders
- Others
- Middle East & Africa Antifungal Drugs Market Distribution Channel Outlook (Revenue, USD Million , 2021-2033)
- Hospital Pharmacies
- Retails Pharmacies
- Others
Reasons to subscribe to Antifungal Drugs Market Outlook databook
- Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
- Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
- Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
- Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
- Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Antifungal Drugs Market Outlook databook
- Our clientele includes a mix of Antifungal Drugs Market Outlook companies, investment firms, advisory firms & academic institutions.
- 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
- Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
- The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the Middle East & Africa Antifungal Drugs Market Outlook, including forecasts for subscribers. This continent databook contains high-level insights into Middle East & Africa Antifungal Drugs Market Outlook from 2021 to 2033, including revenue numbers, major trends, and company profiles.
Middle East Africa Antifungal Drugs Market, 2021-2033 (US$M)
MEA antifungal drugs market statistics, by drug class, 2021-2033 (US$M)
